Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT02699879 · clinicaltrials.gov ↗

COMPLETED

Status

1009

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Pirfenidone

Sponsor

Hoffmann-La Roche